GLP2-T 5 mg (tirzepatide) research material

Buy Tirzepatide 5 mg for laboratory research, listed in this catalog as GLP2-T. It is supplied as lyophilized powder in one boxed 3 mL vial. The original laboratory report links the catalog label to the scientific name.

Compare the available vial sizes

Other presentations in this family are GLP2-T 10 mg, GLP2-T 15 mg, GLP2-T 30 mg. These options change the labeled quantity; choose the amount required for the planned laboratory work and check the records attached to the selected presentation.

GLP2-T is a catalog name for tirzepatide, not native glucagon-like peptide-2. Dual-receptor activity refers to GIP and GLP-1 receptors; it does not mean the vial contains two separately blended peptides.

GIP and GLP-1 receptor research

Coskun and colleagues characterized LY3298176, the development identifier for tirzepatide, using signaling and functional assays in cells expressing incretin receptors. Their cAMP measurements examined GIP and GLP-1 receptor responses to a defined modified peptide.

The published findings concern the authors’ study material and experimental conditions. They provide research context, not certification of this commercial lot, instructions for use or evidence of clinical equivalence.

When comparing a method with the supplied material, check the specified chemical form and modifications. Receptor activity, chromatographic purity and vial content answer separate questions.

Batch documentation and handling

Open COA & Documents and match the product and lot. Read the methods and reported identity, purity and measured content separately. A name or reference formula does not establish an unreported counterion or complete formulation.

The 5 mg value is the labeled amount of material; the 3 mL value is container capacity. Neither specifies a liquid concentration. Use applicable product records and laboratory procedures for storage and preparation.